Jones Financial Companies
VRCA icon

Jones Financial Companies’s Verrica Pharmaceuticals VRCA Stock Holding History

Jones Financial Companies’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$114 Buy
+26
New +$166 ﹤0.01% 4632
2025
Q3 		– Sell
-7
Closed -$38 – 4384
2025
Q2 		$38 Hold
7
– – ﹤0.01% 3981
2025
Q1 		$32 Hold
7
– – ﹤0.01% 3670
2024
Q4 		$51 Hold
7
– – ﹤0.01% 3379
2024
Q3 		$123 Buy
+7
New +$315 ﹤0.01% 2966

Other funds holding VRCA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jones Financial Companies's VRCA Position: Q1 2026 in Review

Jones Financial Companies opened a new position in Verrica Pharmaceuticals (VRCA) in Q1 2026: 26 shares worth $114. The stake represents ﹤0.01% of the portfolio and ranks #4632 among its holdings. This is a return to the name: Jones Financial Companies previously reported a position in VRCA as recently as Q2 2025.

Jones Financial Companies first reported a position in VRCA in Q3 2024 and has held it in 5 quarters since. The position peaked at $123 in Q3 2024. 39 funds tracked by Wall St. Rank hold VRCA as of Q1 2026.

  • Jones Financial Companies held 26 shares of Verrica Pharmaceuticals worth $114 as of Q1 2026.
  • Verrica Pharmaceuticals was a new Jones Financial Companies position in Q1 2026.
  • Verrica Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4632 holding.
  • Jones Financial Companies first reported a position in Verrica Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • Jones Financial Companies's Verrica Pharmaceuticals position peaked at $123 in Q3 2024.
  • 39 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.